Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Liste des pr\u00eats qui ne n\u00e9cessitent pas de remboursement - 2Black Friday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
- 3Vote in favor of the bloom plan that adds a bit of excellence to your life!
- 4'Euphoria' Season 3 trailer includes Eric Dane's final appearance, Jacob Elordi and Sydney Sweeney at the altar and Rue's 'Breaking Bad' era
- 5Instructions to Grasp the Innovation Behind 5G Pinnacles\
- Why most Jewish Israelis back the death penalty for terrorists
- 'Not the moon that I'm used to seeing': Artemis II astronauts describe seeing the far side
- Sheinelle Jones will cohost fourth hour of 'Today' with Jenna Bush Hager: Here's what to know about her
- Hundreds of kilos of protected plant seized by Israel Nature and Parks Authority in Golan
- Putin, Netanyahu discuss Middle East in phone call, Kremlin says
- Figure out How to Alter Your Volvo XC40 for Further developed Solace
- Rubble, mud and hair: How to rebuild a home in Gaza
- Sports Shoes of 2024: Upgrade Execution and Solace
- A Russian fighting for Ukraine conned the Kremlin out of $500,000 by faking his own death
